EPA Registration & Tests
EPA Registration & Tests
CuVerro® alloys have been put through rigorous GLP (Good Laboratory Practices) testing by the EPA to evaluate their effectiveness in killing bacteria1 responsible for many hospital acquired infections (HAIs). The three GLP test protocols used to support EPA registration of antimicrobial copper alloys with public health claims and associated findings:
- Efficacy as a Sanitizer
CuVerro® surfaces kill bacteria1 within two hours, proving its efficacy as a sanitizer.
- Wear Test:
CuVerro® efficacy does not wear out or wear down over time and continues to help inhibit the buildup and growth of bacteria1 between routine cleaning and sanitizing steps.
- Repeated Contamination Test:
CuVerro® surfaces work continuously to kill more than 99% bacteria, 24 hours a day, even after repeated contamination.
These EPA tests used stainless steel as the control since it represents the most common material used in hospital and surgical settings. The data shows that copper efficacy significantly outperformed stainless steel in all three tests.
Public Health Claims
Based on EPA Registration, products made with CuVerro® can be marketed with the following public health claims:
Laboratory testing has shown that when cleaned regularly, this surface:
- Continuously reduces bacterial1 contamination, achieving 99.9% reduction within two hours of exposure, when cleaned regularly.
- Kills greater than 99.9% of Gram-negative and Gram-positive bacteria1 within two hours of exposure.
- Delivers continuous and ongoing antibacterial1 action, remaining effective in killing greater than 99.9% of bacteria1 within two hours.
- Kills greater than 99.9% of bacteria1 within two hours, and continues to kill more than 99% of bacteria1 even after repeated contamination.
- Helps inhibit the buildup and growth of bacteria1 within two hours of exposure between routine cleaning and sanitizing steps.
CuVerro is proven effective against the following bacteria:
- E. coli O157:H7, a food-borne pathogen that has been associated with large-scale food recalls
- Methicillin-Resistant Staphylococcus aureus (MRSA), one of the most virulent strains of antiobic-resistant bacteria and a common culprit of hospital- and community-acquired infections
- Staphylococcus aureus, the most common of all bacterial staphylococcus (i.e. staph) infections that can cause life-threatening diseases, including pneumonia and menigitis
- Vancomycin-Resistant Enterococcus faecalis (VRE), an antibiotic-resistant organism responsible for 4% of all HAIs
- Enterobacter aerogenes, a pathogenic bacterium commonly found in hospitals that causes opportunistic skin infections and impacts other body tissues
- Pseudomonas aeruginsoa, a bacterium that infects the pulmonary tracts, urinary tracts, blood and skin of immunocompromised individuals
EPA Registration Approvals